Breathe Well Live Well
|
BioLineRx's EDP-14, for Treatment of Severe and Persistent Asthma, to Enter …
MarketWatch (press release) BL-9010, a novel bi-specific antibody treatment for severe and persistent asthma, targets and links together two immunological modulators – IgE and CD300a. Allergen-bound IgE activates cells involved in allergic responses, such as mast cells, while … BIOLINERX LTD. : BioLineRx's EDP-14, for Treatment of Severe and Persistent … |
View full post on asthma – Google News
 Zee News |
Fungi In Lungs May Hold Asthma Treatment Clues
Medical News Today There was a time when we assumed the insides of our lungs were devoid of life, apart from our own cells helping us breathe. But now we learn that the lung is home to a wide range of organisms, including fungi. A new study finds that people with asthma … Discovery could help future asthma sufferers |
View full post on asthma – Google News
|
Urban school-based asthma treatment cost-effective
Medical Xpress The researchers found that, per 100 children who received preventative asthma medication, the health benefit was equivalent to approximately 158 symptom-free days per 30 days. The program cost an additional $4,822 per 100 children per month, based on … |
View full post on asthma – Google News
 Daily Mail |
Xolair treatment for asthma sufferers: Don't scrap asthma jab that saved my …
Daily Mail Jack is one of 250,000 people in the UK with severe allergic asthma — a condition that occurs when the body detects a foreign body, such as house dust mites or pollen, but overreacts, producing large amounts of antibodies, triggering an allergic … |
View full post on asthma – Google News
|
Urban School-Based Asthma Treatment Cost-Effective
Journal of the American Academy of Physician Assistants (HealthDay News) – A program to administer asthma medication each day to urban children with asthma reduces symptoms and is cost-effective, according to research published online Feb. 11 in Pediatrics. Katia Noyes, PhD, MPH, from the University of … |
View full post on asthma – Google News
|
New asthma treatment reaches Central Texas
KWKT Waco, TX — Millions of Americans are affected by asthma. Most treatments entail a steroid or inhaler regimen. But a new technology to fight the disease has now landed in Central Texas. Bronchial Thermoplasty- The word goes over many people's heads. |
View full post on asthma – Google News
|
Teva launches asthma treatment inhaler with dose counter
MENAFN.COM Jan 06, 2013 (Menafn – Globes – McClatchy-Tribune Information Services via COMTEX) –Teva Pharmaceutical Industries Ltd. TEVA(tase:TEVA) unit Teva Respiratory has launched its ProAir HFA asthma treatment inhaler with a dose counter for use in … |
View full post on asthma – Google News
|
Teva launches asthma treatment inhaler with dose counter
Globes Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) unit Teva Respiratory has launched its ProAir HFA asthma treatment inhaler with a dose counter for use in patients from age four. The inhaler is for the treatment or prevention of … |
View full post on asthma – Google News
 MENAFN.COM |
Invion starts second phase trial for asthma treatment
MENAFN.COM (MENAFN – ProactiveInvestors – Australia) Invion (ASX: IVX) has initiated the phase II "NIMA" clinical trial to investigate the use of INV102 in patients with mild asthma. The trail, which is funded by the U.S. National Institute of Allergy and … |
View full post on asthma – Google News
 Proactive Investors Australia |
Invion starts second phase trial for asthma treatment
Proactive Investors Australia Invion (ASX: IVX) has initiated the phase II “NIMA” clinical trial to investigate the use of INV102 in patients with mild asthma. The trail, which is funded by the U.S. National Institute of Allergy and Infectious Diseases through a cooperative … |
View full post on asthma – Google News